Abstract
We developed a hybrid ML-DFT framework for rapid screening of drug-nanomaterial interactions (MAE 0.075 eV, DFT-validated). PDOS/Bader analyses reveal charge transfer/coupling mechanisms, enabling scalable ML-driven nanomaterial therapeutics design.

This publication has 44 references indexed in Scilit: